Last reviewed · How we verify
ISOPROPYL ALCOHOL
Isopropyl Alcohol is a marketed product primarily indicated for the prevention of infection in minor cuts, holding a well-established position in the antiseptic market. Its key strength lies in the protection of a key composition patent, which is set to expire in 2028, providing a period of exclusivity and competitive edge. The primary risk is the potential increase in competition following the patent expiry in 2028.
At a glance
| Generic name | ISOPROPYL ALCOHOL |
|---|---|
| Modality | Small molecule |
| Phase | FDA-approved |
| First approval | 2000 |
Approved indications
- Prevention of infection in minor cuts
- Prevention of infection in scrapes
- Prevention of infection in burns
Common side effects
Key clinical trials
- CLinical Evaluation of ANtiseptic Skin Preparation in Revision Total Joint Arthroplasty of the Hip and Knee (NA)
- Evaluation of Daily Disposable Toric Soft Lenses Manufactured With an Alternative Hydration Process (NA)
- Enasidenib (AG-221) Maintenance Post Allogeneic HCT in Patients With IDH2 Mutation (PHASE2)
- HEMA-free Universal Adhesives for Restoring Non-carious Cervical Lesions (NA)
- Enasidenib and Azacitidine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia and IDH2 Gene Mutation (PHASE2)
- Effect of Ice Pack and Warm Gel Pad Use During Drain Removal on Anxiety, Comfort, Physiological Parameters, and Patient Satisfaction Undergoing Open Urological Surgery (NA)
- Randomized Controlled Trial of Vaginal Cryotherapy for Pelvic Floor Myofascial Pain (NA)
- VCOM Pain Free Research Collaborative (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |